• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有髓系恶性肿瘤的布卢姆综合征患者的染色体畸变。

Chromosomal aberrations in Bloom syndrome patients with myeloid malignancies.

作者信息

Poppe B, Van Limbergen H, Van Roy N, Vandecruys E, De Paepe A, Benoit Y, Speleman F

机构信息

Center for Medical Genetics, De Pintelaan 185, B-9000 Gent, Belgium.

出版信息

Cancer Genet Cytogenet. 2001 Jul 1;128(1):39-42. doi: 10.1016/s0165-4608(01)00392-2.

DOI:10.1016/s0165-4608(01)00392-2
PMID:11454428
Abstract

Bloom syndrome (BS) predisposes affected individuals to a wide variety of neoplasms including hematological malignancies. Thus far, cytogenetic findings in hematological neoplasms have been reported in only a few BS patients. We present the karyotypic findings in a BS patient diagnosed with acute myeloid leukemia (AML), FAB subtype M1, and a review of the literature, showing the preferential occurrence of total or partial loss of chromosome 7 in BS patients with AML or myelodysplastic syndromes (MDS).

摘要

布卢姆综合征(BS)使受影响个体易患多种肿瘤,包括血液系统恶性肿瘤。迄今为止,仅在少数BS患者中报道了血液系统肿瘤的细胞遗传学发现。我们报告了一例被诊断为急性髓系白血病(AML)、FAB亚型M1的BS患者的核型分析结果,并对文献进行了综述,结果显示在患有AML或骨髓增生异常综合征(MDS)的BS患者中,7号染色体全部或部分缺失的情况较为常见。

相似文献

1
Chromosomal aberrations in Bloom syndrome patients with myeloid malignancies.患有髓系恶性肿瘤的布卢姆综合征患者的染色体畸变。
Cancer Genet Cytogenet. 2001 Jul 1;128(1):39-42. doi: 10.1016/s0165-4608(01)00392-2.
2
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.荧光原位杂交检测核型正常的急性髓系白血病中隐匿性染色体畸变的发生率及意义
Leukemia. 2002 Sep;16(9):1745-51. doi: 10.1038/sj.leu.2402605.
3
Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.骨髓增生异常综合征和急性髓细胞白血病患者骨髓间充质基质细胞中的染色体畸变
Exp Hematol. 2007 Feb;35(2):221-9. doi: 10.1016/j.exphem.2006.10.012.
4
Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.与骨髓增生异常综合征转化为急性髓系白血病相比,初发急性髓系白血病伴三系骨髓发育异常的细胞遗传学分析
Int J Oncol. 1998 Jun;12(6):1259-62. doi: 10.3892/ijo.12.6.1259.
5
Myelodysplastic syndrome associated with monosomy 7 in a child with Bloom syndrome.患有布卢姆综合征的儿童中与7号染色体单体相关的骨髓增生异常综合征。
Cancer Genet Cytogenet. 2000 Jan 1;116(1):44-6. doi: 10.1016/s0165-4608(99)00099-0.
6
Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics.在原发性骨髓增生异常综合征演变为急性髓系白血病且细胞遗传学正常的情况下,隐匿性染色体畸变很少见。
Leuk Res. 2004 Feb;28(2):171-7. doi: 10.1016/s0145-2126(03)00221-2.
7
Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia.骨髓增生异常综合征中位于5q31的PURA基因和位于7p13的PURB基因缺失以及向急性髓系白血病的进展。
Leukemia. 2001 Jun;15(6):954-62. doi: 10.1038/sj.leu.2402108.
8
Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?110例伴有5号染色体异常的造血系统疾病的荧光原位杂交分析:原发性与治疗相关的骨髓增生异常综合征-急性髓系白血病真的有区别吗?
Cancer Genet Cytogenet. 2007 Jul 1;176(1):1-21. doi: 10.1016/j.cancergencyto.2007.01.013.
9
[Aberrations of chromosome 5 in myeloid malignancies with complex chromosome abnormalities].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1257-60.
10
Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.通过分子细胞遗传学技术组合在髓系恶性肿瘤中揭示的7号染色体结构畸变。
Cancer Genet Cytogenet. 2007 Feb;173(1):10-6. doi: 10.1016/j.cancergencyto.2006.09.003.

引用本文的文献

1
A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variant.一例表现为治疗相关性骨髓增生异常综合征的布卢姆综合征,携带一种新型 BLM 基因突变。
Int J Hematol. 2024 May;119(5):603-607. doi: 10.1007/s12185-024-03751-x. Epub 2024 Mar 15.
2
Genetic Predisposition to Hematologic Malignancies in Childhood and Adolescence.儿童和青少年血液系统恶性肿瘤的遗传易感性
Mediterr J Hematol Infect Dis. 2023 May 1;15(1):e2023032. doi: 10.4084/MJHID.2023.032. eCollection 2023.
3
Chitosan as possible inhibitory agents and delivery systems in leukemia.
壳聚糖作为白血病中可能的抑制剂和递送系统。
Cancer Cell Int. 2021 Oct 18;21(1):544. doi: 10.1186/s12935-021-02243-w.
4
Multidisciplinary management of endocrinopathies and treatment-related toxicities in patients with Bloom syndrome and cancer.Bloom 综合征患者癌症相关内分泌并发症和治疗毒性的多学科管理。
Pediatr Blood Cancer. 2021 Feb;68(2):e28815. doi: 10.1002/pbc.28815. Epub 2020 Nov 23.
5
Hereditary myeloid malignancies.遗传性髓系恶性肿瘤。
Best Pract Res Clin Haematol. 2019 Jun;32(2):163-176. doi: 10.1016/j.beha.2019.05.001. Epub 2019 May 3.
6
RECQ helicases are deregulated in hematological malignancies in association with a prognostic value.RECQ 解旋酶在血液系统恶性肿瘤中失调,并与预后价值相关。
Biomark Res. 2016 Feb 13;4:3. doi: 10.1186/s40364-016-0057-4. eCollection 2016.
7
Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.染色体畸变在急性髓系白血病克隆多样性和进展中的作用。
Leukemia. 2015 Jun;29(6):1243-52. doi: 10.1038/leu.2015.32. Epub 2015 Feb 12.
8
Potential relationship between inadequate response to DNA damage and development of myelodysplastic syndrome.对DNA损伤反应不足与骨髓增生异常综合征发生之间的潜在关系。
Int J Mol Sci. 2015 Jan 5;16(1):966-89. doi: 10.3390/ijms16010966.
9
DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.急性髓系白血病中的DNA损伤积累与修复缺陷:对发病机制、疾病进展及化疗耐药性的影响
Chromosoma. 2014 Dec;123(6):545-61. doi: 10.1007/s00412-014-0482-9. Epub 2014 Aug 12.
10
Acute myeloid leukaemia after treatment for acute lymphoblastic leukaemia in girl with Bloom syndrome.患有布卢姆综合征的女孩在接受急性淋巴细胞白血病治疗后发生急性髓系白血病。
J Genet Syndr Gene Ther. 2013 Sep 18;4(8). doi: 10.4172/2157-7412.1000177.